A previous study confirmed STEAP2 was downregulated in breast cancer, and its upregulation inhibited tumor proliferation, invasion, and metastasis by suppressing PI3K-Akt signaling pathway in vitro and in vivo [43]. This evidence concerns the gene AKT1 and breast carcinoma.